China, Oct. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Optimization and Clinical Validation of a Dilution Protocol for Quantifying Ultra-High Concentration HBV DNA in Serum Samples'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134460
Registration Time: 2026/10/15
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of Nanchang University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345181
Published by HT Digital Content Services with permission from Health Daily Digest....